Rezultati - Allen C. Ho
- Showing 1 - 20 results of 34
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration od Brandon Busbee, Allen C. Ho, David M. Brown, Jeffrey S. Heier, Iván J. Suñer, Zhengrong Li, Roman G. Rubio, Phillip Lai
Izdano 2013Artigo -
12
Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration od Allen C. Ho, Brandon Busbee, Carl D. Regillo, Mark R. Wieland, Sherri A. Van Everen, Zhengrong Li, Roman G. Rubio, Phillip Lai
Izdano 2014Artigo -
13
Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti–Vascular Endothelial Growth Factor Injections od Anthony Obeid, Xinxiao Gao, Ferhina S. Ali, Christopher M. Aderman, Abtin Shahlaee, Murtaza K. Adam, Sundeep Kasi, Leslie Hyman, Allen C. Ho, Jason Hsu
Izdano 2018Artigo -
14
-
15
ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION od Anton Orlin, Dexter Hadley, Woohyok Chang, Allen C. Ho, Gary C. Brown, Richard Kaiser, Carl D. Regillo, Ashlee N. Godshalk, Audun Lier, Brian Kaderli, Dwight Stambolian
Izdano 2011Artigo -
16
American Academy of Ophthalmology Intelligent Research in Sight (IRIS®) Registry and the IRIS Registry Analytic Center Consortium od Cecilia S. Lee, Marian Blazes, Anja Lorch, Suzann Pershing, Leslie Hyman, Allen C. Ho, Julia A. Haller, Joan W. Miller, Emily Y. Chew, Flora Lum, Aaron Lee
Izdano 2022Editorial -
17
-
18
Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report od Artur V. Cideciyan, Samuel G. Jacobson, Allen C. Ho, Alexandra V. Garafalo, Alejandro J. Román, Alexander Sumaroka, Arun K. Krishnan, Małgorzata Świder, Michael R. Schwartz, Aniz Girach
Izdano 2021Artigo -
19
Early and Long-Term Responses to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data od Víctor H. González, Joanna Campbell, Nancy M. Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J. Augustin, Julia Ma, Allen C. Ho, Vaishali Patel, Scott M. Whitcup, Pravin U. Dugel
Izdano 2016Artigo -
20
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA od Pravin U. Dugel, Joanna Campbell, Szilárd Kiss, Anat Loewenstein, Vanessa Shih, Xiaoshu Xu, Nancy M. Holekamp, Albert J. Augustin, Allen C. Ho, Víctor H. González, Scott M. Whitcup
Izdano 2018Artigo
Iskalna orodja:
Sorodne teme
Medicine
Ophthalmology
Internal medicine
Surgery
Visual acuity
Retinal
Macular degeneration
Bevacizumab
Chemotherapy
Ranibizumab
Computer science
Biology
Argus
Optometry
Programming language
Visual prosthesis
Adverse effect
Randomized controlled trial
Retinitis pigmentosa
Retrospective cohort study
Diabetes mellitus
Diabetic retinopathy
Endocrinology
Gene
Physics
Aflibercept
Audiology
Choroidal neovascularization
Clinical trial
Genetics